A bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups.
Chemical ID:
MESH:C006780
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[bisphenol A co-treated with tributyltin] results in increased expression of PPARG protein; [Dietary Fats co-treated with bisphenol A] results in increased expression of PPARG mRNA; lithospermate B inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; Wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA]
bisphenol A analog results in increased expression of PPARG mRNA; bisphenol A results in increased expression of PPARG mRNA; bisphenol A results in increased expression of PPARG protein
bisphenol A results in increased expression of PPARG; bisphenol A results in increased expression of PPARG mRNA; bisphenol A results in increased expression of PPARG protein
2-chloro-5-nitrobenzanilide inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; 4-phenylbutyric acid inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPARG mRNA; [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PPARG protein; [bisphenol A results in decreased expression of MIR27B] which results in increased expression of PPARG mRNA; [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of PPARG mRNA; bisphenol A analog binds to and results in increased activity of PPARG protein; bisphenol A binds to and results in decreased activity of PPARG protein; bisphenol A binds to and results in increased activity of PPARG protein; bisphenol A inhibits the reaction [HNF1B protein binds to PPARG promoter]; bisphenol A inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]; Fulvestrant inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; HNF1B protein inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; HNF1B protein inhibits the reaction [bisphenol A results in increased expression of PPARG protein]; PPARG protein affects the reaction [bisphenol A results in decreased expression of HNF1B mRNA]; PPARG protein affects the reaction [bisphenol A results in increased expression of CD36 mRNA]; PPARG protein affects the reaction [bisphenol A results in increased expression of FABP4 mRNA]; PPARG protein affects the reaction [bisphenol A results in increased expression of NR1H3 mRNA]; PPARG protein affects the reaction [bisphenol A results in increased secretion of APLN protein]; PPARG protein affects the reaction [Fulvestrant inhibits the reaction [bisphenol A inhibits the reaction [INS protein results in increased uptake of Glucose]]]; RTKI cpd inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; SREBF1 protein affects the reaction [bisphenol A results in increased expression of PPARG mRNA]; sulforaphane inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; U 0126 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]
[1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein; [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein; [bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] promotes the reaction [[Dietary Sucrose co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]; [bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the expression of PPARG mRNA; [bisphenol A co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] affects the methylation of PPARG promoter; bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]; bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]; bisphenol A promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]; Dietary Fats promotes the reaction [bisphenol A results in increased expression of PPARG mRNA]; Dietary Fats promotes the reaction [bisphenol A results in increased expression of PPARG protein]; ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; ginsenoside Rh1 inhibits the reaction [bisphenol A results in increased expression of PPARG protein]; MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]]; MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]]; Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]; sulforaphane inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]; T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]
